The present application relates to a novel and efficient method for producing novel substituted 5-fluoro-lHpyrazolopyridines of the formula (VI) which are suitable as an intermediate for producing medicaments and for producing medicaments for the treatment and/or Prophylaxis of cardiovascular disorders. In particular, the 5-fluoro-lH-pyrazolopyridines of the formula (VI) are suitable for producing the Compound of the formula (I) which serves for producing medicaments, for producing medicaments for the treatment and/or Prophylaxis of cardiovascular disorders.
